Background. Many people with Parkinson's disease (PD) experience cognitive decline. It is not known whether cognitive training or noninvasive brain stimulation are effective at alleviating cognitive deficits in PD. Objective. To examine cognitive training and non-invasive brain stimulation interventions for cognition in PD. Methods. An extensive search was conducted of published and unpublished studies in online databases. Studies were selected if they were controlled trials examining standard (not individualized) or tailored (individualized) cognitive training, repetitive transcranial magnetic stimulation (rTMS), or transcranial direct current stimulation (tDCS) in PD, with outcomes measured by standardized neuropsychological tests. Results. Fourteen controlled trials met inclusion criteria. For executive function, the pooled effect size (Hedges' g) for cognitive training (standard and tailored combined) was small (g = 0.42) but statistically significant (95% CI 0.15-0.68). The pooled effect for standard cognitive training (alone) was medium (g = 0.51) and significant (95% CI 0.16-0.85). For attention/working memory, small pooled effect sizes were found when combining standard and tailored cognitive training (g = 0.23; 95% CI 0.02-0.44) and for standard cognitive training alone (g = 0.29; 95% CI 0.04-0.53), both significant. For memory, small but significant pooled effect sizes were also found when combining standard and tailored cognitive training and for standard cognitive training alone. Conclusions. The results suggest that standard and tailored cognitive training may improve executive function, attention/working memory, and memory in PD. Future studies must adopt randomized controlled trial designs to explore the therapeutic potential of these interventions.
Introduction
While Parkinson disease (PD) is classified as a movement disorder, approximately 30% of people with PD experience cognitive symptoms that negatively affect quality of life. 1 Five domains of cognition are potentially vulnerable to mild cognitive impairment in PD: long-term memory, attention/working memory, visuospatial abilities, executive function, and language. 2, 3 While there is limited evidence supporting pharmacological treatment for people with comorbid cognitive impairments in PD, 4 nonpharmacological interventions are being considered as potential therapeutic techniques for improving cognition. 5 Evidence suggests that standard (not individualized) cognitive training and tailored (individualized) cognitive training appears to improve cognition in PD. 6, 7 Likewise, repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) may also improve cognition in PD. 8, 9 However, a recent review of nonpharmacological intervention in PD (predominantly for executive functions), reported a lack of methodological rigor, which reduced the quality of the results. 5 rTMS studies in PD have varied by intervention length (1-12 sessions), stimulation frequency (0.2-50 Hz), target locations (dorsolateral prefrontal or motor cortices), and approach to stimulation: intermittent theta-burst or repetitive TMS. [10] [11] [12] [13] [14] [15] Consequently, studies administering a lower frequency (eg, 5 Hz) of rTMS over the left dorsolateral prefrontal cortex (affecting executive function) will likely produce different cortical effects compared with a higher frequency (eg, 50 Hz) of rTMS over the motor cortices (affecting motor function). Most studies have also assessed cognitive domains as secondary outcomes, rather than targeting interventions primarily toward improvement of cognition. 13, 16 For tDCS, more consistent methodology has been adopted (eg, 2 mA stimulation of prefrontal cortices) but findings are limited by lack of controlled designs. 8, 17 Furthermore, many studies have not included controlled designs, 8, 17 albeit recent, placebo-controlled trials have adopted more stringent methodological designs and these still support cognitive training and brain stimulation for improving cognition in PD. 18, 19 In addition, a recent metaanalysis of cognitive training in PD found improvements in working memory, processing speed, and executive function. 20 Research, however, needs to examine the independent therapeutic effects of standard and tailored cognitive training 21 and whether rTMS or tDCS are viable nonpharmacological interventions for improving cognition in PD. The present study builds on the recent meta-analysis of cognitive training, by examining the efficacy of controlled trials of standard cognitive training, tailored cognitive training, tDCS, and rTMS studies in PD and provides a synthesis of current results with recommendations for future, nonpharmacological interventions.
Method
This meta-analysis was conducted in accordance with the Preferred Reporting of Systematic Reviews and Meta-Analyses (PRISMA) statement (see Supplementary  Table S1 ). 22 
Search Strategy and Study Selection
Key words (eg, cognitive training OR tDCS OR rTMS; see Supplementary Table S2 ) were systematically searched in online databases for published articles (eg, MEDLINE, PubMed, Wiley Online Library) and gray literature (e.g., OpenGrey, NTIS). Search parameters were from first date of publication to May 27, 2016 . Reference lists were also searched. Studies were included in the meta-analysis if (1) they recruited participants with idiopathic PD diagnosed by a neurologist or geriatrician using the United Kingdom's Parkinson's Disease Society Brain Bank Clinical Criteria;
(2) they evaluated rTMS, tDCS, or cognitive training interventions; (3) they used a controlled design; (4) primary outcomes were measured by standardized neuropsychological tests; and (5) data were provided to calculate an effect size (means, SDs, t or F values, and probability values). One author (B.J.L) systematically screened article titles and abstracts in line with selection criteria and identified preliminary articles for inclusion. Two authors (B.J.L and A.M.L) independently screened selected articles to determine the final studies for inclusion. Any disagreements were resolved through discussion.
Data Extraction and Risk of Bias Assessment
The data extracted from each study included participants, interventions, comparisons, outcomes, and study design (PICOS). Cognitive outcomes were categorised in accordance with the Movement Disorder Society (MDS) Task Force recommendations for cognitive domains: executive function, attention/working memory, memory, visuospatial abilities, language, and global cognition. 23 Outcomes assessing processing speed (not addressed by the MDS Task Force) were categorized within the "attention/working memory" domain. Preand post-intervention means and standard deviations were extracted for cognitive outcomes. Where outcome means and standard deviations were not reported, probability values for between-group comparisons based on post-intervention outcomes were extracted to compute effect sizes. The Cochrane Collaboration tool was used to assess risk of bias among studies included in this meta-analysis. 24 The risk of bias assessment tool classifies individual studies as having low, high, or unclear risk of bias across 6 domains; sequence generation, allocation concealment, blinding, selective reporting, and other biases. 24 
Statistical Analysis and Publication Bias
Comprehensive Meta-Analysis (CMA) version 3.3.070 was used to complete data analyses. 25 The change score method from pre-to post-intervention was used to calculate the absolute magnitude of change for intervention and control groups. Effect sizes for each outcome were then computed as Hedge's g. 25 Cognitive domain effect sizes were calculated by computing the mean effect within each domain and adjusting the mean variance by 0.8 to correct for intercorrelation among outcomes. 25 Domain effect sizes and adjusted variances were then pooled using a random-effects model, with 95% confidence intervals. 25, 26 Egger's regression asymmetry test and the fail-safe N were used to assess publication bias. 27, 28 For studies with 2 or more intervention groups but 1 control group, the control group was divided into the same number of groups. 25 This ensured that each participant's data were analyzed only once.
Heterogeneity Analysis
Heterogeneity was explored using Cochrane's Q and I 2 statistics. A statistically significant Q statistic suggests a difference between an observed and true effect. 29 However, the Q statistic may overestimate this difference in small sample sizes. If Q was significant, the I 2 statistic was used as an estimate of the percentage of variation across the samples due to heterogeneity. Values for I 2 are expressed as a percentage, with suggested values of 25% (low), 50% (moderate), and 75% (high) used to categorize levels of heterogeneity. 29
Results

Search Results
In total, 13 162 titles and abstracts were systematically screened in online databases. Seventy-one studies examined nonpharmacological interventions in PD. Fifty-seven were excluded as they were not rTMS, tDCS, or cognitive training interventions (13) , multiple interventions (eg, cognitive training combined with physical exercise) (4), study protocols (3), case studies (2), not assessing cognition with standardised outcomes (9) , not all participants diagnosed with PD (1), provided insufficient data to be meta-analyzed (eg, conference abstracts and authors did not respond to follow-up) (6), or not controlled trials (17) . Two additional studies were excluded as we were unsuccessful in obtaining missing data from the authors. Since one of these excluded studies was the only tDCS study to be considered in this meta-analysis, it was therefore not possible to examine tDCS (see Figure 1 ).
Study Characteristics
Fourteen controlled trials met inclusion criteria (see Table  1 ): 3 rTMS, 9, 11, 12 3 tailored cognitive training, 6,30,31 and 8 standard cognitive training studies. 7, 19, [32] [33] [34] [35] [36] [37] Articles were published from 2006 to 2014, with all but one published in the past 5 years. Petrelli et al 19 provided data for 2 comparisons, comparing structured and unstructured training groups against a single control group.
Assessment of Risk of Bias
Two studies had low risk, 19,35 5 high risk, 6, 31, 32, 34, 37 and 7 unclear risk of bias. 7, 9, 11, 12, 30, 33, 36 Of the 5 studies with high risk, 3 did not use a randomization sequence for allocating participants, 6,32,34 3 did not blind outcome assessments, 31,34 37 and 1 did not conceal participant group allocation. 34 Of the 7 studies with unclear risk, 5 did not clearly describe the randomization sequence generation, 7, 9, 30, 33, 36 3 did not sufficiently describe blinding of outcome assessments, 11,12,33 and 2 did not adequately describe concealment of group allocation. 33, 36 Only 3 of the cognitive training studies were double-blind. 19, 32, 35 However, double-blinding is difficult to achieve in such intervention studies. 24 
Executive Function
Ten studies assessed executive functions pre-and posttreatment. Supplementary Figure S1 shows a forest plot of effect sizes, 95% confidence limits, and heterogeneity results, revealing that there was a significant, small benefit of combined cognitive training on executive outcomes. 38 A medium and statistically significant pooled effect for executive function was found for standard cognitive training alone. No other effects were significant ( Table 2 ).
Attention and Working Memory
Ten cognitive intervention studies and 1 rTMS study explored effects on attention/working memory (see Table 2 and Supplementary Figure S2 ). Therefore, only cognitive training pooled effect sizes were calculated. Small and statistically significant effects for combined and standard cognitive training improving attention/working memory were identified.
Memory
Six studies examined the effect of cognitive training on memory. No rTMS studies assessed memory. Meta-analysis revealed a small effect of combined and standard cognitive training on memory: both statistically significant (see Table  2 and Supplementary Figure S3 ).
Visuospatial Abilities, Language, and Global Cognition
Four studies examined the effect of cognitive training (3 standard and 1 tailored) on visuospatial abilities in PD, but pooled effects were not significant (see Table 2 and Supplementary Figure S4 ). Four standard and 1 tailored cognitive training study, and 1 rTMS study examined effects on global cognition in PD. Meta-analysis revealed no significant effects (see Table 2 and Supplementary Figure S5 ). No controlled studies examined language impairment.
Publication Bias
Publication bias statistics were calculated for significant, pooled effect sizes by cognitive domain. Despite a nonsignificant Egger's regression for combined cognitive training effects on executive function, P = .25, only 14 nonsignificant results would be required to render this effect zero, suggesting publication bias. Likewise, Egger's regression for standard cognitive training effects on executive function was not significant (P = .54), but needing only 7 nonsignificant results suggests publication bias. Likewise, for attention/working memory Egger's regression was not significant for combined (P = .77) or standard training (P = .58) but fail-safe Ns of 2, for both, suggest publication bias. Finally, for memory, Egger's regression was significant for combined cognitive training (P = .01) and only 3 nonsignificant results would be needed to undermine this significant pooled effect. Also for memory, Egger's regression for standard cognitive training effects was not significant (P = . 27 ), yet a low fail-safe N (N = 1) suggests publication bias.
Sensitivity Analyses
Petrelli et al 19 reported means and standard error values adjusted for covariates and not raw data, Sammer et al 31 did not report pre/post data and effect sizes were computed using probability values from postintervention outcomes, and Ell 33 conducted a short cognitive training intervention (8 minutes) compared with the longer interventions included in this meta-analysis. Therefore, 3 sensitivity analyses were conducted to determine if removing these studies would significantly affect pooled effect estimates (see Table 3 ).
Discussion
This meta-analysis is the first to provide distinct, pooled effect sizes for standard (not individualized) and tailored (individualized) cognitive training and rTMS interventions for cognition in PD. When considered together, standard and tailored cognitive training studies appear to improve executive function, albeit only by a small amount. When analyzed separately, perhaps because of the small number of studies, executive function was no longer improved by tailored cognitive training, but standard cognitive training appeared to have a more moderate effect. This nonsignificant effect for tailored cognitive training may represent a type II error, given that a small effect size was observed but only three tailored cognitive training studies were included in this meta-analysis. There were insufficient studies for a formal comparison of the relative effects of standard and tailored cognitive training. Thus, more controlled trials of tailored cognitive training are needed to determine if this modality is more or less efficacious than a standard (nonindividualized) intervention. Executive function did not appear to improve in the 2 rTMS studies investigated. 11, 12 Given that preliminary results of rTMS trials 13 report improvements in cognition in PD, more detailed exploration of this therapeutic technique is required. People with PD and cognitive impairment demonstrate deficits in attention/working memory. 39 When considered together, attention/working memory was improved by standard and tailored cognitive training and by standard training alone. This finding conflicts with those of Leung et al 20 who reported a medium and significant effect for working memory, but a small and non-significant negative effect for attention. Unlike this meta-analysis, however, Leung et al 20 included one study that had a large negative effect on attention. 40 This study compared computerized cognitive training (intervention group) to computerized sport-related video gaming (control group). But sport-related video games have improved cognition in older adults, 41 which Zimmermann et al 40 also reported. Inclusion of this study in the previous meta-analysis led to inclusion of a large negative effect for cognitive training on attention, but inversely included a large positive effect for computerized sportrelated gaming on attention (rather than an effect favoring a control group). The current meta-analysis excluded this study to ensure only controlled comparisons were included in pooled effects, and this approach found positive effects for combined and standard cognitive training improving attention/working memory in PD.
Only one controlled rTMS study examined attention/ working memory in PD, reporting no significant changes. 9 However, several noncontrolled rTMS studies have shown improvements in cognition. [14] [15] [16] 42 Before concluding whether rTMS is or is not helpful in alleviating cognitive deficits in PD, more controlled rTMS studies are needed.
While the primary cognitive impairments in PD are characterized by frontal dysfunction, memory impairment is also common. 43 Both standard and combined standard and tailored cognitive training offered small improvements in memory. This corresponds with a meta-analysis of memory training in healthy older adults, which found significant memory improvements posttraining. 44 Inconsistent with studies in mild cognitive impairment, 45 standard and combined cognitive training did not appear to produce improvements in global cognition-despite all studies reporting a positive effect of cognitive training on global cognition. Compared with larger cognitive training trials improving all cognitive domains in healthy older adults, 46 the studies included in this meta-analysis may have been underpowered (ie, small N), which resulted in nonsignificant effects. Future studies need to recruit larger samples to ensure sufficient statistical power in cognitive training trials in PD.
Because of the heterogeneous nature of cognitive impairment in PD, individuals may demonstrate deficits in visuospatial and language domains. 39 There was no impact of cognitive training on visuospatial abilities across the 4 studies examined in this analysis. No controlled studies evaluated language impairment. Although language deficits are rare in PD, 47 future studies should include standardized neuropsychological assessment of these domains. 23 In addition to the cognitive outcomes, sensitivity analyses examined whether removing the covariate adjusted results of Petrelli et al 19 affected corresponding effect estimates. Several changes suggest that this study's adjusted results had a large impact on attention/working memory, visuospatial, memory and global cognition effects. 19 Pooling effect sizes with adjusted results may not, however, demonstrate an accurate effect of standard cognitive training on these cognitive domains in PD. Adjusting results for the effect of covariates will likely underrepresent the true effect of an intervention (eg, cognitive training), by accounting for a proportion of variance in outcome variables. Sensitivity analyses also examined whether removing Sammer et al's 31 effect sizes (computed with probability statistics) or Ell's 33 results from a short cognitive training intervention, would affect pooled effect estimates. No changes in statistical significance of effects were observed.
For rTMS, methodological differences between studies may have resulted in the nonsignificant effect for executive function. Benninger et al 11 administered 50-Hz intermittent theta burst rTMS over the primary motor and dorsolateral prefrontal cortices, whereas Benninger et al 12 applied 50-Hz rTMS over primary motor cortices. Compared with the short-term effects found in rTMS studies, intermittent theta burst rTMS has been shown to increase the duration of synaptic plasticity by delivering 3 shorter pulses of stimulation (every 200 ms) to specific neuronal groups. 48 Conversely, earlier studies delivered longer stimulation (20-30 minutes) and showed significant improvements in cognition in PD. 9, 13, 16 Length and frequency of stimulation may, therefore, produce variable effects on synaptic connections and associated cognitive functions. Moreover, Benninger et al 12 assessed executive function but stimulated primary motor cortices not associated with executive function improvement. Having said this, rTMS is relatively nonfocal, often activating a combination of cortical systems that may have interacting effects. 48 In their earlier study, Benninger et al 11 used the 5-cm rule to target the dorsolateral prefrontal cortex, which provides widespread stimulation across motor and prefrontal sites. 49 Consequently, rTMS over primary motor cortices may activate broader cortical systems that impact prefrontal areas (thus affecting executive function). Despite these differences, both studies reported positive effects in support of rTMS for improving cognition in PD. Future studies should build on these preliminary results by exploring the therapeutic potential of this noninvasive intervention for people with cognitive impairment and PD.
A lack of sensitivity of executive function and attention/ working memory measures for detecting change in PD may also have contributed to the null rTMS pooled effect sizes. For Pal et al, 9 the Trail Making Test-Part A (TMT-A) was 1 of 3 outcomes used to compute an attention/working memory effect. 50 However, a meta-analysis comparing TMT-A performance between people with frontal deficits to those with posterior deficits found no significant difference between groups. 51 This suggests that the TMT-A is not sensitive to differences between frontal and nonfrontal cognitive impairments, yet impairments in PD are associated with deficits in prefrontal (dorsolateral and ventrolateral) cortices. 52 In addition, both rTMS 11, 12 studies assessing executive function used the Frontal Assessment Battery (FAB). 53 The FAB has, however, low sensitivity (66.3%) in detecting executive function impairments related to dementia in PD. 54 These limiting factors may account for the nonsignificant executive function and attention/working memory effect estimates and must be acknowledged when interpreting the results.
Methodological heterogeneity of cognitive training interventions also limited this meta-analysis. Jean et al 55 recommend 6 to 20 cognitive training sessions (up to 15 hours) completed within 12 weeks, to be most effective, when compared with longer and more costly interventions. However, studies ranged between 8 minutes (computerbased rule learning task 33 ) and 45 hours (Sudoku puzzle every day for 6 months 34 ). Having said this, removing Ell 33 from pooled effects resulted in no changes in corresponding effect estimates and recent cognitive training studies have implemented more homogenous interventions (9-18 hours). 19, 32, 35 Type of cognitive training (eg, single-participant vs group-based training, or computer vs paper/pencil tasks) also varied between studies. Seven studies 7, 30, [32] [33] [34] 36, 37 administered training to participants individually, whereas 3 studies 6,19,35 conducted group-based training. Compared with participants who complete cognitive training alone, group based training has shown greater efficacy in healthy older adults by providing additional benefits, including trainer supervision, encouragement in performance, and social interaction among participants. 46 In addition, most trials included in this meta-analysis administered computerbased cognitive training 6, 30, 32, 37 (compared with paper/ pencil tasks) and there is an ever-growing body of research in support of computer-based interventions in PD 56 and other neurodegenerative disorders (eg, Alzheimer's disease 57 ). Furthermore, several studies 7, 9, 30, 33, 36 did not adequately describe their randomization sequence generation and 3 studies 6,32,34 did not randomize participants to intervention and control groups. Methodological limitations in controlled trials undermine the validity and generalizability of results, while perpetuating uncertainty for an intervention's potential to alleviate symptoms for people with PD. Future trials need to build on current scientific evidence to establish the most efficacious parameters (eg, length, frequency, and type of training) for cognitive interventions in PD, and conduct randomized controlled trials in accordance with the CONSORT (Consolidated Standards of Reporting Trials) statement to provide reliable and externally valid evidence of these nonpharmacological interventions. 58 It is also important to note that only 2 studies in this meta-analysis included participants with cognitive impairment. Administering cognitive training, tDCS, or rTMS to people with PD and normal cognition may result in a ceiling effect of the therapeutic potential of these interventions to improve cognition. Future studies should therefore examine the potential of these interventions for people with cognitive deficits (eg, mild cognitive impairment and dementia) in PD.
The literature relating to the impact of either rTMS or tDCS in PD on cognitive function is limited, and very few studies employed a controlled design. In addition to a small N, there was evidence of bias within trials and bias in publication for combined and standard cognitive training effects on executive function, attention/working memory, and memory. Although violation of Rosenthal's fail-safe N suggests included studies may not be a true representation of the population effect, 13 162 studies were systematically searched in published and unpublished databases and only 14 met inclusion criteria. This extensive search, inclusive of gray literature, suggests these significant fail-safe N results may not be an accurate indication of publication bias.
This study highlights the need for randomized controlled trials of cognitive training (standard and tailored), rTMS, and tDCS for improving cognition in PD. Future interventions need to compare standard (not individualized) and tailored (individualized) cognitive training, and examine whether combining cognitive training with brain stimulation further improves cognition in PD. Studies should also compare interventions between participant groups with varying severity of cognitive impairment, to provide insight into which stages of disease progression are most likely to benefit from cognitive training and brain stimulation. Furthermore, previous studies report associations between cognitive decline and impaired activities of daily living, depression, and quality of life in PD. 36, [59] [60] [61] [62] Future clinical trials should therefore include these variables as primary outcomes to explore the potential of these nonpharmamcological interventions for improving neuropsychiatric and practical domains.
This meta-analysis builds on previous results to provide the first individual pooled effect sizes for standard and tailored cognitive training and brain stimulation interventions for cognition in PD. Despite the significant prevalence of cognitive impairment in PD, there is a considerable lack of empirical evidence to support the improvement of cognitive functioning. An extensive literature search uncovered 14 controlled trials, 3 rTMS, 3 tailored cognitive training, and 8 standard cognitive training. The only controlled trial of tDCS did not provide sufficient data for inclusion. Based on the available studies, there is evidence to support the use of standard and tailored cognitive training for improving executive function, attention/working memory, and memory in PD. Although limited by available studies, the results of this meta-analysis provide a promising starting point for future nonpharmacological interventions in PD.
